Cover Image

Disease Burden and Treatment Patterns of Psoriasis in Russia: A Real-World Patient and Dermatologist Survey

Abstract Introduction Data regarding disease burden and quality of life (QoL) for patients with psoriasis from Russia are limited. The objective of this study was to describe the demographic and clinical characteristics, comorbidities, and treatment patterns of systemic therapy eligible psoriasis pa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexey A. Kubanov (Author), Andrey L. Bakulev (Author), Tatiana V. Fitileva (Author), Evgenia Novoderezhkina (Author), Isabelle Gilloteau (Author), Haijun Tian (Author), Tanya Howe (Author), Guilhem Pietri (Author)
Format:	Book
Published:	Adis, Springer Healthcare, 2018-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psoriasis: clinical and epidemiological features and therapy issues
by: A. L. Bakulev, et al.
Published: (2018)

Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database
by: Steven R. Feldman, et al.
Published: (2017)

Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients
by: David Rosmarin, et al.
Published: (2024)

The Actual Challenges of Biologics Treatment in Patients with Psoriasis
by: Andrey L. Bakulev
Published: (2020)

Psoriasis in Pediatrics
by: Andrey L. Bakulev, et al.
Published: (2020)

The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022)

Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19
by: Alexey A. Kubanov, et al.
Published: (2020)

Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
by: Alexey A. Kubanov, et al.
Published: (2023)

Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab
by: Andrey L. Bakulev, et al.
Published: (2022)

Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic
by: Tiago Torres, et al.
Published: (2021)

Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
by: Andrey L. Bakulev, et al.
Published: (2023)

A survey of treatment practices in management of psoriasis patients among dermatologists of Kerala
by: Mohammed Nazeer, et al.
Published: (2019)

Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective
by: Riley K. Spencer, et al.
Published: (2023)

Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients
by: Rajagopalan M, et al.
Published: (2022)

Experiences of Dermatologists and Patients Regarding Psoriasis and Its Connection to Psoriatic Arthritis in Saudi Arabia
by: Fatani MI, et al.
Published: (2024)

Towards Comprehensive Newborn Hearing and Genetic Screening in Russia: Perspectives of Implementation
by: Svetlana Chibisova, et al.
Published: (2024)

Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
by: Andrew Blauvelt, et al.
Published: (2024)

Infiltrative-Suppurative Form of Scalp Microsporia in a Child with Generalized Pustular Psoriasis of von Zumbusch: Clinical Case
by: Andrey L. Bakulev, et al.
Published: (2021)

Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence
by: Tina Bhutani, et al.
Published: (2024)

Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study
by: Hao Trong Nguyen, et al.
Published: (2023)

Socio-economic burden of chronic migraine in Russia
by: A. A. Kolbin, et al.
Published: (2019)

Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
by: Giampiero Girolomoni, et al.
Published: (2024)

Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients
by: A. L. Bakulev
Published: (2017)

Are dermatologists greedy?
by: Ghosh Sanjay
Published: (1996)

Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
by: A. L. Bakulev
Published: (2019)

Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician Survey
by: Brian S. Kim, et al.
Published: (2024)

Considerable variation among Iranian dermatologists in the knowledge and attitudes regarding the use of biologic agents to manage psoriasis,
by: Mina Almasi-Nasrabadi, MD, et al.
Published: (2019)

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists
by: Alvaro Gonzalez-Cantero, MD, PhD, et al.
Published: (2023)

Strategy "treat to target" for patients with psoriasis. Relevant issues to biological therapy persistence
by: A. L. Bakulev
Published: (2017)

Being an academic dermatologist in Turkey: Young academic dermatologists' perspectives on dermatology
by: Sezgi Sarıkaya Solak, et al.
Published: (2021)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021)

Search for predictors of psoriatic arthritis in patients with psoriasis
by: Olga G. Artamonova, et al.
Published: (2023)

Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients
by: A. L. Bakulev
Published: (2017)

General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France
by: Angèle Soria, et al.
Published: (2021)

Deucravacitinib, a TYK2 inhibitor, safety in psoriasis and psoriatic arthritis: What should a dermatologist know?
by: Inês Pereira Amaral, et al.
Published: (2023)

Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians
by: Emilio Berna-Rico, et al.
Published: (2023)

Unmet Needs and Treatment Preference of Systemic Treatments for Moderate-to-Severe Psoriasis from the Perspectives of Patients and Dermatologists in China
by: Yehong Kuang, et al.
Published: (2024)

Kawasaki disease for dermatologists
by: Aman Gupta, et al.
Published: (2016)

The dermatologists' case for the bidet
by: Yoseph Dalia, MD, MBA, et al.
Published: (2023)

A priceless dermatologist
Published: (2012)